PET/CT helps predict mortality in metastatic breast cancer patients

09/14/2011 | AuntMinnie.com (free registration)

Researchers at last week's American Society of Clinical Oncology Breast Cancer Symposium reported that in breast cancer patients with bone metastases, higher standardized uptake values on PET/CT scans could indicate greater risk of death. Prognostication for metastatic breast cancer has been difficult, but modern PET/CT may serve as a "complementary and clinically useful prognostic tool," said researcher Dr. Komal Jhaveri from the Memorial Sloan-Kettering Cancer Center in New York.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA